What Researchers Did
Researchers investigated the efficacy of hyperbaric oxygen therapy (HBOT) for diabetic foot ulcers (DFUs) and identified predictors of amputation in 146 patients receiving HBOT alongside standard treatment.
What They Found
Among 146 patients with chronic DFUs, 87.5% experienced complete healing (69.6%) or significant improvement (17.9%) with HBOT. Amputation occurred in 23.2% of patients (15.0% minor, 8.2% major), and mortality was significantly higher in the amputation group (47.1% versus 21.4%, p=0.007). Key amputation predictors included Wagner grade, duration of diabetes, new wound formation, and C-reactive protein levels.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers might benefit from hyperbaric oxygen therapy as an adjunct to standard care, potentially improving healing rates and reducing amputation risk. Recognizing risk factors like Wagner grade and C-reactive protein levels could help guide early intervention and personalized treatment strategies.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's findings are limited by its single-center, non-randomized design, necessitating further multicenter, prospective, randomized studies for stronger evidence.